Literature DB >> 18688832

Synthesis and biochemical evaluation of selective inhibitors of class II fructose bisphosphate aldolases: towards new synthetic antibiotics.

Matthieu Fonvielle1, Mathieu Coinçon, Racha Daher, Nicolas Desbenoit, Katarzyna Kosieradzka, Nathalie Barilone, Brigitte Gicquel, Jurgen Sygusch, Mary Jackson, Michel Therisod.   

Abstract

We report the synthesis and biochemical evaluation of selective inhibitors of class II (zinc-dependent) fructose bisphosphate aldolases. The most active compound is a simplified analogue of fructose bisphosphate, bearing a well-positioned metal chelating group. It is a powerful and highly selective competitive inhibitor of isolated class II aldolases. We report crystallographic studies of this inhibitor bound in the active site of the Helicobacter pylori enzyme. The compound also shows activity against Mycobacterium tuberculosis isolates.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18688832     DOI: 10.1002/chem.200800857

Source DB:  PubMed          Journal:  Chemistry        ISSN: 0947-6539            Impact factor:   5.236


  12 in total

1.  Rational design, synthesis, and evaluation of new selective inhibitors of microbial class II (zinc dependent) fructose bis-phosphate aldolases.

Authors:  Racha Daher; Mathieu Coinçon; Matthieu Fonvielle; Petra M Gest; Marcelo E Guerin; Mary Jackson; Jurgen Sygusch; Michel Therisod
Journal:  J Med Chem       Date:  2010-11-11       Impact factor: 7.446

Review 2.  Targeting Metalloenzymes for Therapeutic Intervention.

Authors:  Allie Y Chen; Rebecca N Adamek; Benjamin L Dick; Cy V Credille; Christine N Morrison; Seth M Cohen
Journal:  Chem Rev       Date:  2018-09-07       Impact factor: 60.622

3.  Withdrawn

Authors: 
Journal:  Infect Disord Drug Targets       Date:  2012-11-16

4.  Active site loop dynamics of a class IIa fructose 1,6-bisphosphate aldolase from Mycobacterium tuberculosis.

Authors:  Scott D Pegan; Kamolchanok Rukseree; Glenn C Capodagli; Erica A Baker; Olga Krasnykh; Scott G Franzblau; Andrew D Mesecar
Journal:  Biochemistry       Date:  2013-01-18       Impact factor: 3.162

5.  Glycolytic and non-glycolytic functions of Mycobacterium tuberculosis fructose-1,6-bisphosphate aldolase, an essential enzyme produced by replicating and non-replicating bacilli.

Authors:  Maria de la Paz Santangelo; Petra M Gest; Marcelo E Guerin; Mathieu Coinçon; Ha Pham; Gavin Ryan; Susan E Puckett; John S Spencer; Mercedes Gonzalez-Juarrero; Racha Daher; Anne J Lenaerts; Dirk Schnappinger; Michel Therisod; Sabine Ehrt; Jurgen Sygusch; Mary Jackson
Journal:  J Biol Chem       Date:  2011-09-23       Impact factor: 5.157

6.  Highly Selective Inhibitors of Class II Microbial Fructose Bis-phosphate Aldolases.

Authors:  Racha Daher; Michel Therisod
Journal:  ACS Med Chem Lett       Date:  2010-03-11       Impact factor: 4.345

7.  Active site remodeling during the catalytic cycle in metal-dependent fructose-1,6-bisphosphate aldolases.

Authors:  Benoit Jacques; Mathieu Coinçon; Jurgen Sygusch
Journal:  J Biol Chem       Date:  2018-03-28       Impact factor: 5.157

8.  Rational design, synthesis and evaluation of first generation inhibitors of the Giardia lamblia fructose-1,6-biphosphate aldolase.

Authors:  Zhimin Li; Zhengang Liu; Dae Won Cho; Jiwen Zou; Maozhen Gong; Robert M Breece; Andrey Galkin; Ling Li; Hong Zhao; Gabriel D Maestas; David L Tierney; Osnat Herzberg; Debra Dunaway-Mariano; Patrick S Mariano
Journal:  J Inorg Biochem       Date:  2010-12-30       Impact factor: 4.155

9.  A noncompetitive inhibitor for Mycobacterium tuberculosis's class IIa fructose 1,6-bisphosphate aldolase.

Authors:  Glenn C Capodagli; Wafik G Sedhom; Mary Jackson; Kateri A Ahrendt; Scott D Pegan
Journal:  Biochemistry       Date:  2013-12-24       Impact factor: 3.162

10.  Molecular modeling, dynamics studies and virtual screening of Fructose 1, 6 biphosphate aldolase-II in community acquired- methicillin resistant Staphylococcus aureus (CA-MRSA).

Authors:  Pramod Kumar Yadav; Gurmit Singh; Budhayash Gautam; Satendra Singh; Madhu Yadav; Upasana Srivastav; Brijendra Singh
Journal:  Bioinformation       Date:  2013-02-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.